The Subjective Experience of Skeletal Muscle Relaxants: A Comprehensive Clinical and Pharmacological Review

Introduction: The Dual Nature of Muscle Relaxation

The experience of taking a skeletal muscle relaxant is a complex and often paradoxical phenomenon, representing a delicate balance between targeted therapeutic relief and the widespread, often unintended, effects of nervous system depression.

The question of how these medications make a person feel has no single, simple answer.

The subjective experience is profoundly shaped by the specific drug administered, the unique physiology and psychology of the individual, and, most critically, the underlying medical condition being treated.¹

This report will provide an exhaustive analysis of the physical, cognitive, and emotional sensations associated with this diverse class of medications, synthesizing data from clinical literature, pharmacological research, and patient-reported outcomes to create a nuanced understanding of their effects.

To comprehend how muscle relaxants feel, one must first recognize the two distinct worlds of muscle dysfunction they are prescribed to manage.

This fundamental distinction governs the entire patient experience, from the therapeutic goal to the duration of treatment and the profile of expected effects.

1. Spasticity: This is a chronic neurological condition characterized by a velocity-dependent increase in muscle tone, resulting in stiffness, hypertonicity, and involuntary jerks known as clonus.² It is not a disease in itself but a consequence of damage to upper motor neurons in the brain or spinal cord. Conditions that cause spasticity include multiple sclerosis (MS), cerebral palsy (CP), spinal cord injury, stroke, and traumatic brain injury.² For patients with spasticity, muscle relaxants—specifically a class called antispastics—are used for long-term management to improve function, reduce pain, and facilitate care.² The desired feeling is a sustained release from debilitating tightness and involuntary movements.
2. Muscle Spasm: This refers to a temporary, involuntary, and often painful contraction of a muscle or muscle group, typically associated with an acute musculoskeletal injury, such as low back pain, neck strain, or tension headaches.² For these conditions, a class of drugs called antispasmodics is prescribed for short-term symptomatic relief, usually for no more than two to three weeks, as an adjunct to rest and physical therapy.⁵ The desired feeling is the acute “unknotting” of a painfully tight muscle.

It is also crucial to understand that “skeletal muscle relaxant” is a functional, not a chemical, classification.¹

The agents within this group are structurally and pharmacologically heterogeneous, meaning they achieve their effects through a wide variety of mechanisms.¹

This report will deconstruct this heterogeneity, explaining how the distinct actions of each drug give rise to a unique profile of feelings, from therapeutic relief to a spectrum of adverse effects.

Section 1: The Neurological Basis of Sensation: How Muscle Relaxers Work

The subjective experience of taking a muscle relaxant is a direct manifestation of its interactions with the body’s complex signaling systems.

To understand why these drugs produce their characteristic feelings, it is essential to first understand how they work.

The fact that the majority of these medications are not muscle-specific but rather are general depressants of the central nervous system (CNS) is the single most important concept in explaining their effects.

This non-specificity is why the most common feelings reported—drowsiness, dizziness, and fatigue—are systemic and cognitive, not localized to the muscles.

The sensation is not merely one of muscle relaxation; it is one of whole-body and mind sedation.

This global effect also explains the significant risks associated with their use, particularly when combined with other substances that depress the CNS, such as alcohol or opioids.⁹

1.1 The Central Dimmer Switch: Understanding CNS Depression

The primary mechanism for most skeletal muscle relaxants is depression of the central nervous system, which comprises the brain and spinal cord.²

An effective analogy for this mechanism is that of a dimmer switch for the body’s entire electrical system.

Rather than selectively turning off the “light” in a single overactive muscle, these drugs turn down the master dimmer, reducing the intensity of neuronal activity throughout the CNS.¹³

This global reduction in nerve signaling is what produces the overarching feelings of sedation, calmness, and muscle relaxation.

However, this same mechanism is responsible for the most common and often undesirable side effects.

By dimming the lights everywhere, these drugs can also lead to feelings of dizziness, poor coordination, mental slowness, and confusion.⁵

This non-specific action is a double-edged sword: it makes the drugs effective for relieving muscle spasms that are centrally mediated, but it also creates a broad side-effect profile and a high potential for dangerous interactions.⁷

1.2 Amplifying the Brain’s Brakes: The Role of the GABA System

Several of the most potent and widely used muscle relaxants achieve their CNS-depressant effects by targeting the gamma-aminobutyric acid (GABA) system.¹⁷

GABA is the primary inhibitory neurotransmitter in the brain, responsible for calming neuronal activity and preventing over-excitation.

Using a simple analogy, GABA acts as the nervous system’s “brake pedal.” Medications that enhance the GABA system are, in effect, pressing this brake pedal harder, slowing down the transmission of signals between nerve cells and inducing a state of relaxation.¹⁸

Different drugs interact with this system in subtly different ways, leading to distinct subjective experiences.

• Benzodiazepines (e.g., Diazepam): Drugs like diazepam (Valium) bind to a specific site on the $GABA_A$ receptor complex. This action doesn’t press the brake pedal itself but makes the brake pedal more sensitive. It increases the frequency with which the receptor’s chloride ion channel opens in response to GABA, allowing more negatively charged chloride ions to enter the neuron.²⁰ This influx makes the neuron hyperpolarized, or less likely to fire. This mechanism is highly effective for reducing both spasticity and spasms but is also responsible for the profound sedation associated with benzodiazepines.⁴ This powerful braking action also carries a high risk of tolerance, physical dependence, and abuse, which can contribute to a psychological feeling of “needing” the drug to function or feel normal.²²
• Baclofen (Lioresal): Baclofen provides a more nuanced braking action. It acts as an agonist, or activator, at a different type of GABA receptor known as $GABA_B$.⁴ When activated,
  $GABA_B$ receptors work presynaptically to reduce the influx of calcium ions into the nerve terminal. This, in turn, decreases the release of excitatory neurotransmitters like glutamate.⁴ Instead of just enhancing inhibition, baclofen also turns down the volume on excitation. This mechanism makes it a first-line treatment for spasticity, as it is considered at least as effective as diazepam but causes significantly less sedation.⁴
• Carisoprodol (Soma): The mechanism of carisoprodol, a notoriously potent and controversial muscle relaxant, also involves the $GABA_A$ receptor. However, its action is more akin to that of barbiturates than benzodiazepines.¹⁵ It directly modulates the receptor to enhance GABA’s effects, an action that explains the profound sedative and, for some, euphoric feelings reported by users. Its primary active metabolite is meprobamate, a substance with a well-established abuse potential similar to benzodiazepines, which further clarifies the drug’s high potential for dependence and its classification as a Schedule IV controlled substance.²⁶

1.3 Modulating the Message: Alternative Central Pathways

Not all centrally-acting muscle relaxants rely on the GABA system.

Several other agents target different neurotransmitter pathways in the brain and spinal cord, resulting in unique subjective experiences and distinct side-effect profiles.

• Cyclobenzaprine (Flexeril): This widely prescribed antispasmodic is structurally related to the tricyclic antidepressant family of drugs.²⁸ Its primary muscle-relaxant effect is believed to stem from its activity in the brain stem, rather than at the spinal cord level.²⁸ Recent research suggests that cyclobenzaprine is a potent antagonist of the
  $5-HT_2$ serotonin receptor, and this action is likely responsible for its antispasmodic properties.²⁸ Its structural and pharmacological similarity to tricyclic antidepressants explains its strong anticholinergic (atropine-like) side effects, which manifest as the distinct feelings of a very dry mouth, blurred vision, and sometimes confusion or urinary retention.⁹ This serotonergic activity also creates a risk for a potentially life-threatening condition called serotonin syndrome if combined with other drugs that increase serotonin levels, such as certain antidepressants.⁹ The overall feeling is often one of intense drowsiness.
• Tizanidine (Zanaflex): Tizanidine is an $\alpha_2$-adrenergic agonist, pharmacologically similar to the blood pressure medication clonidine.⁴ It works centrally to reduce spasticity by depressing the excitatory feedback signals that travel from the muscles back to the spinal cord, which would normally increase muscle tone.⁴ This unique mechanism is directly responsible for its characteristic side-effect profile. In addition to the profound sedation common to many muscle relaxants, users of tizanidine may experience feelings associated with low blood pressure (hypotension) and a slow heart rate (bradycardia), such as dizziness, lightheadedness, and fainting spells.³¹
• Methocarbamol (Robaxin): The precise mechanism of action for methocarbamol remains largely unknown, a surprising fact given its long history of use.²⁹ It is generally categorized as a CNS depressant that likely works by inhibiting interneuronal activity in the spinal cord and midbrain.³⁴ However, its exact molecular target has not been established. More recent animal studies have introduced a new possibility: that methocarbamol may also have a direct effect on muscles by blocking sodium channels, which would cause the muscle to stay relaxed for longer.³³ This potential dual mechanism—a central depressant effect combined with a peripheral muscle effect—could explain why some patients report effective muscle relaxation with comparatively less sedation than other agents.³³

1.4 Cutting the Power Locally: Direct Muscle Action

A small but important subset of muscle relaxants bypasses the central nervous system entirely, acting directly on the skeletal muscle fibers.

This offers a fundamentally different kind of subjective experience.

The analogy here shifts from a “central dimmer switch” to “unplugging the machine on the factory floor.” While central agents turn down the command center, these drugs go to the muscle itself and interfere with the mechanics of contraction.

• Dantrolene (Dantrium): Dantrolene is the primary example of a direct-acting agent used for chronic spasticity. It works by inhibiting the process of excitation-contraction coupling within the muscle fiber.⁴ Specifically, it blocks the release of calcium ions from an intracellular storage unit called the sarcoplasmic reticulum.²⁰ Since calcium is the trigger for muscle contraction, limiting its release directly reduces the muscle’s ability to contract. Because dantrolene does not depress the CNS, it is generally thought to cause less of the cognitive fog, confusion, or sedation associated with centrally-acting drugs.³⁶ However, its non-selective action on
  all skeletal muscles can lead to a profound and sometimes undesirable feeling of generalized muscle weakness.³⁰ This direct action also carries a significant and well-documented risk of severe, sometimes fatal, liver toxicity.¹
• Botulinum Toxin (Botox): While typically administered by specialists and not taken orally like other muscle relaxants, botulinum toxin is another important direct-acting agent. It works at the neuromuscular junction—the point where nerve meets muscle—to prevent the release of the neurotransmitter acetylcholine.³⁷ Without acetylcholine, the nerve cannot signal the muscle to contract, resulting in a localized and temporary paralysis.³⁷ The feeling produced by botulinum toxin injections is one of targeted weakness or immobility in the treated muscles, not a systemic sensation of relaxation or sedation.

Section 2: The Spectrum of Feeling: From Therapeutic Relief to Adverse Effects

The subjective experience of taking a muscle relaxant encompasses a wide spectrum of sensations, ranging from the intended therapeutic relief to a host of common and sometimes severe adverse effects.

A crucial point to recognize is that the line between a “side effect” and a “desired effect” can be highly subjective and context-dependent.

For a patient whose severe muscle spasms prevent sleep, the profound sedation caused by a drug like cyclobenzaprine is not an unwanted side effect but a welcome therapeutic benefit that enables restorative rest.²¹

Conversely, for an individual misusing a drug like carisoprodol for non-medical reasons, the feelings of sedation and euphoria are not side effects at all, but rather the primary goals of use.²

This blurring of clinical definitions highlights the critical role of individual psychology and intent in shaping how these medications make a person feel.

A purely clinical list of side effects fails to capture the full, nuanced human experience.

2.1 The Desired Sensation: Relief from Pain and Involuntary Contraction

At its best, the feeling produced by a muscle relaxant is one of profound relief.

The specific nature of this relief depends on the condition being treated.

• For Spasticity: Patients with conditions like multiple sclerosis or cerebral palsy describe the feeling as a release from a state of constant, exhausting muscle tension.² The sensation is one of muscles finally “letting go” after being perpetually stiff, tight, and prone to involuntary jerks (clonus).³ This physical release translates into a greater sense of bodily freedom, improved range of motion, easier completion of activities of daily living like dressing or hygiene, and a significant reduction in the chronic pain that often accompanies severe hypertonicity.⁵ As one user of baclofen for multiple sclerosis reported, “I never felt so good in so many years” after starting the medication, highlighting the dramatic improvement in quality of life that can be achieved.⁴¹
• For Acute Spasms: For individuals with an acute musculoskeletal injury, such as a severe low back strain, the feeling is one of a painfully tight, “knotted” muscle finally unclenching.⁷ This relaxation leads to a direct and often immediate reduction in sharp, localized pain, allowing the person to move more freely, find a comfortable position for rest, and more effectively participate in physical therapy, which is crucial for long-term recovery.⁹ Patient testimonials vividly capture this sense of relief. Users of carisoprodol (Soma), in particular, have described it as a “lifesaver” that provides relief from “horrible pain” when other medications have failed.⁴² One user with mitochondrial myopathy and severe back pain reported that after taking Soma, they could “stand up out of my recliner without it feeling like my spine is being ripped out!!”.⁴⁴

2.2 The Pervasive Sensations: Drowsiness, Dizziness, and Fatigue

The most common feelings associated with centrally-acting muscle relaxants are a direct result of their CNS-depressant effects.

These sensations are pervasive, affecting the entire body and mind.

• Drowsiness/Somnolence: This is the most frequently reported sensation across nearly all centrally-acting muscle relaxants.⁴⁵ The feeling can range from a mild, pleasant sleepiness to a profound sedation that significantly impairs one’s ability to perform daily activities, such as driving or working.³⁸ The intensity of this feeling varies considerably between drugs. Cyclobenzaprine and tizanidine are known to be highly sedating.²¹ In contrast, metaxalone is recognized as the least sedating option, and methocarbamol is also considered to be on the less sedating end of the spectrum.¹¹ User-reported data reflects these differences; in one comparison, drowsiness was reported by 20% of cyclobenzaprine users, compared to just 8.7% of baclofen users and 8.3% of carisoprodol users.⁴⁹
• Dizziness/Lightheadedness: A common feeling of unsteadiness or a sensation of spinning (vertigo) is another hallmark of CNS depression.⁴⁶ This can lead to a loss of balance and significantly increases the risk of falls, which is a critical safety concern, especially for older adults who are more sensitive to these effects.³ The feeling of dizziness is often exacerbated by sudden changes in posture, such as standing up too quickly from a sitting or lying position (a phenomenon known as orthostatic hypotension), which is a particular risk with tizanidine.³¹
• Fatigue/Weakness (Asthenia): This is a feeling distinct from simple sleepiness. It is a sensation of physical exhaustion, a profound lack of energy, and generalized muscle weakness.³¹ This feeling of asthenia is particularly prominent with baclofen and tizanidine.⁴⁶ For dantrolene, this feeling of weakness is not a side effect but a primary therapeutic action, as it works by directly reducing the contractile force of all skeletal muscles.³⁰

2.3 The Cognitive Fog: Confusion, Impaired Memory, and Delirium

The global depression of the central nervous system does not spare higher-order cognitive functions.

Many users experience a “cognitive fog,” a feeling of mental slowness, difficulty concentrating, and impaired thinking.⁵

• Confusion and Disorientation: This is a distressing feeling of being mentally muddled, disoriented, or unable to think clearly. It can range from mild confusion to severe delirium.³⁰ This risk is especially high in elderly patients and those with pre-existing cognitive or renal impairment.⁵ A landmark study on baclofen revealed a particularly stark risk: when prescribed at a high dose to patients with low kidney function (less than 30% of normal), approximately 1 in 25 were hospitalized for severe confusion and other cognitive symptoms within a few days. This was a dramatic increase compared to a risk of less than 1 in 500 for similar patients not taking the drug.⁵²
• Memory Impairment: Long-term use of muscle relaxants can negatively impact concentration and memory.⁴⁸ Methocarbamol, for example, has been specifically associated with reports of short-term memory loss.³⁵
• Hallucinations: While rare, some muscle relaxants can induce the frightening experience of seeing or hearing things that are not real.⁷ This is a known risk with tizanidine, affecting up to 3% of patients in some clinical trials, and has also been reported with orphenadrine.³¹ Hallucinations can also be a symptom of overdose or abrupt withdrawal from other agents, such as carisoprodol or baclofen.⁷

2.4 The Body’s Broader Response: A Profile of Physical Side Effects

Beyond the primary CNS effects, muscle relaxants can produce a wide range of other physical sensations as they interact with various systems throughout the body.

• Anticholinergic Feelings: Several muscle relaxants, most notably cyclobenzaprine and orphenadrine, block the action of the neurotransmitter acetylcholine, leading to a cluster of distinct side effects.²⁸

• Dry Mouth (Xerostomia): A very common and bothersome feeling of oral dryness is a hallmark side effect, particularly with cyclobenzaprine and tizanidine.⁹
• Blurred Vision: A sensation of unfocused vision is reported with cyclobenzaprine, methocarbamol, and orphenadrine.⁹
• Urinary Retention: This is a sensation of being unable to fully empty the bladder and is a known side effect of baclofen and orphenadrine.⁴⁶

• Gastrointestinal Distress: Feelings of nausea, stomach upset, and constipation are commonly reported with many muscle relaxants.¹ Some users have reported particularly severe gastrointestinal pain, gas, and vomiting with methocarbamol.⁵⁶ Dantrolene is uniquely associated with a risk of severe, debilitating diarrhea.⁴⁶
• Cardiovascular Sensations: Users may experience noticeable changes in heart function. A feeling of a racing, rapid, or irregular heartbeat (tachycardia) can occur with cyclobenzaprine and orphenadrine, which are related to their anticholinergic properties.⁹ Conversely, a feeling of low blood pressure (hypotension) or an unusually slow heartbeat (bradycardia) is a characteristic effect of the
  $\alpha_2$-agonist tizanidine.³¹

Section 3: A Comparative Analysis of Subjective Experiences

The term “muscle relaxant” groups together a pharmacologically diverse set of drugs, each producing a unique constellation of feelings.

A comparative analysis reveals a significant disconnect between the findings of formal clinical trials and the lived experiences reported by patients.

For conditions like acute low back pain, rigorous studies often show that antispasmodic muscle relaxants offer minimal, if any, benefit over non-steroidal anti-inflammatory drugs (NSAIDs) like ibuprofen, while carrying a greater burden of side effects.²

Yet, despite this lack of compelling clinical evidence, these drugs are widely prescribed, and patient-reported satisfaction for some agents, like carisoprodol, is exceptionally high.⁴²

This paradox suggests that the subjective experience—the “feeling” of relief—provided by these drugs may be profound for a subset of patients in a way not fully captured by traditional clinical trial endpoints.

It also raises the possibility that the powerful sedative, and in some cases euphoric, effects of these CNS depressants are being either misinterpreted as or valued equally to pure muscle relaxation by patients seeking any form of relief from pain and discomfort.

What patients feel and value in a “muscle relaxer” may be fundamentally different from what clinicians are attempting to measure in controlled studies.

3.1 Antispasmodics for Musculoskeletal Pain

These agents are typically prescribed for short-term relief of muscle spasms associated with acute, painful conditions like back or neck strain.⁶

• Carisoprodol (Soma):

• The Feeling: The experience of taking carisoprodol is frequently described by users as a uniquely powerful and fast-acting sense of relief and relaxation, often touted as superior to all other muscle relaxants.⁴² This therapeutic effect is almost always accompanied by significant drowsiness. For some, this sedation progresses to a feeling of mild euphoria, a sensation that directly contributes to its high potential for misuse and abuse.⁷
• Patient vs. Physician Perspective: The story of carisoprodol is defined by a stark contrast in perspectives. Patient satisfaction ratings are extraordinarily high, with an average of 8.9 out of 10 on Drugs.com.⁴³ Users with chronic, debilitating pain often refer to it as a “lifesaver”.⁴² In stark contrast, physicians express significant safety concerns regarding its potential for addiction and misuse, with some rating its efficacy as weak.⁶⁰ This chasm between profound patient-reported benefit and documented clinical risk makes carisoprodol one of the most controversial drugs in its class.
• Cyclobenzaprine (Flexeril):

• The Feeling: The subjective experience of cyclobenzaprine is overwhelmingly dominated by sedation. Users frequently report feeling “knocked out,” “sleepy,” or experiencing a “hangover” effect that can linger into the next day.⁴⁴ This profound drowsiness is coupled with strong anticholinergic effects, leading to a prominent and often uncomfortable feeling of a very dry mouth.⁹
• User Ratings: The heavy side-effect burden is reflected in its user ratings. Cyclobenzaprine has a lower average rating of 6.0 out of 10, with a high percentage of reviewers (30%) reporting a negative experience, often citing the overwhelming sedation and dry mouth.⁵⁰
• Methocarbamol (Robaxin):
• The Feeling: Methocarbamol is often described as offering a milder experience. Many users feel it provides effective muscle relaxation with less intense sedation compared to other agents, making it a more tolerable option for daytime use.³³ However, a substantial number of users—39% in one survey—report that it “did not seem to work” at all, suggesting its efficacy is highly variable.³⁵ Some users also report unusual sensations, such as vivid dreams, a metallic taste in the mouth, or, paradoxically, anxiety and a racing heart.³⁵
• Metaxalone (Skelaxin):
• The Feeling: Metaxalone is generally considered to provide the “cleanest” subjective experience among the antispasmodics. It is the least likely to make a person feel drowsy or sedated.¹¹ For many users, the primary feeling is one of targeted muscle relaxation with minimal cognitive or systemic side effects, making it a preferred option when mental alertness is required.

3.2 Antispastics for Neurological Conditions

These agents are used for long-term management of spasticity resulting from conditions like MS, spinal cord injury, or cerebral palsy.⁶

• Baclofen (Lioresal):

• The Feeling: The primary therapeutic feeling is a reduction in chronic muscle stiffness and spasticity. However, this is often coupled with a distinct and sometimes problematic feeling of generalized muscle weakness (hypotonia), which can lead to clumsiness, unsteadiness, and difficulties with balance and gait.⁵⁴ A significant cognitive side effect is a feeling of mental fog or confusion, a risk that is particularly acute in elderly patients and those with impaired kidney function.⁵³
• Withdrawal: The feeling of abrupt baclofen withdrawal is severe and dangerous. It is not merely uncomfortable but can manifest as a state of extreme agitation, high fever, hallucinations, and seizures, requiring immediate medical attention.⁵⁴
• Tizanidine (Zanaflex):

• The Feeling: The experience of taking tizanidine is marked by intense sedation, comparable to or even exceeding that of cyclobenzaprine.²¹ This feeling is combined with sensations related to its
  $\alpha_2$-agonist activity, namely low blood pressure. This can manifest as a feeling of profound dizziness, lightheadedness, or even fainting.³¹ An overwhelming sensation of dry mouth is also a very common and frequently reported component of the experience.³¹
• Withdrawal: Similar to other drugs that affect blood pressure, abrupt withdrawal from tizanidine can feel like a hypertensive crisis, with a racing heart (tachycardia) and a sharp, dangerous increase in blood pressure.³²
• Dantrolene (Dantrium):
• The Feeling: Dantrolene offers a unique subjective experience. Because it acts directly on muscle tissue and not the CNS, there is less of the “drowsy,” “dizzy,” or “confused” feeling that characterizes the centrally-acting agents.³⁶ Instead, the primary sensation is one of profound, generalized muscle weakness that affects the entire body.⁴ While this weakness is the source of its therapeutic effect on spastic muscles, it can also be debilitating, affecting posture, strength, and overall physical function.

Table 1: Comparative Profile of Common Skeletal Muscle Relaxants

Drug Name (Generic/Brand)	Class	Primary Mechanism of Action	Dominant Subjective Feeling(s)	Key Common Side Effects	Major Risks/Warnings
Carisoprodol (Soma)	Antispasmodic	Modulates $GABA_A$ receptors (barbiturate-like) 15	Powerful, rapid relief with heavy sedation; potential for euphoria 42	Drowsiness, dizziness, headache 30	High abuse potential (Schedule IV); dependence; severe withdrawal 7
Cyclobenzaprine (Flexeril)	Antispasmodic	Brain stem action; $5-HT_2$ antagonist 28	Intense sedation (“hangover” effect); strong feeling of dry mouth 44	Drowsiness, dry mouth, dizziness, fatigue 9	Serotonin syndrome risk; anticholinergic effects; avoid in cardiac patients 8
Methocarbamol (Robaxin)	Antispasmodic	General CNS depression (mechanism not fully known) 33	Milder relaxation with less sedation; efficacy is highly variable 33	Drowsiness, dizziness, lightheadedness, blurred vision 35	May cause urine discoloration; potential for GI upset 56
Metaxalone (Skelaxin)	Antispasmodic	General CNS depression (mechanism not fully known) 29	“Clean” relaxation with minimal sedation or cognitive effects 11	Drowsiness, dizziness, headache, irritability 30	Least sedating; risk of serotonin syndrome 30
Baclofen (Lioresal)	Antispastic	$GABA_B$ receptor agonist 4	Release from spasticity coupled with a feeling of muscle weakness and unsteadiness 54	Drowsiness, dizziness, weakness, confusion, nausea 30	Severe withdrawal syndrome (seizures, hallucinations); risk of confusion in renal impairment 53
Tizanidine (Zanaflex)	Antispastic / Antispasmodic	Central $\alpha_2$-adrenergic agonist 4	Intense sedation with feelings of low blood pressure (dizziness, faintness) 31	Dry mouth, somnolence, asthenia (weakness/fatigue), dizziness 31	Hypotension; liver injury risk; severe withdrawal (hypertension, tachycardia) 31
Dantrolene (Dantrium)	Antispastic	Direct-acting; blocks calcium release in muscle 4	Profound, generalized muscle weakness without significant CNS sedation 4	Muscle weakness, drowsiness, dizziness, severe diarrhea 30	High risk of severe, potentially fatal liver toxicity 1
Diazepam (Valium)	Antispasmodic / Antispastic	$GABA_A$ receptor modulator (benzodiazepine) 20	Strong relaxation with significant sedation and anxiolysis 4	Drowsiness, fatigue, muscle weakness, ataxia 30	High abuse potential (Schedule IV); dependence; severe withdrawal; respiratory depression risk 22

Section 4: The Perils and Pitfalls: Misuse, Dependence, and Dangerous Interactions

While muscle relaxants can offer significant therapeutic benefits, their powerful effects on the central nervous system carry inherent risks.

The danger of these medications lies in their deceptive nature.

They are prescribed for legitimate medical conditions like pain and spasticity, yet their primary mechanism—CNS depression—produces feelings of sedation and relaxation that are pharmacologically indistinguishable from those of other well-known drugs of abuse.

This creates a subtle and often unintentional pathway from appropriate therapeutic use to misuse, dependence, and addiction.

This risk is profoundly amplified when muscle relaxants are combined with other CNS depressants like alcohol, a socially acceptable and readily available substance.

The very feeling of intensified sedation that a user might seek from such a combination is the direct mechanism that makes it so potentially lethal.

4.1 The Illicit “High”: Euphoria, Dissociation, and Abuse

For individuals using muscle relaxants for non-medical reasons, the goal is not to relieve a spasm but to induce a specific set of feelings: a pleasant state of euphoria, a deep and calming relaxation, and sometimes dissociation—a feeling of being detached from one’s own body or from reality.²

The muscle relaxant most notoriously associated with abuse is carisoprodol (Soma).

The U.S. Drug Enforcement Administration (DEA) classified carisoprodol as a Schedule IV controlled substance in 2012, acknowledging its significant potential for abuse.²⁷

This potential is largely attributed to its primary metabolite, meprobamate, a tranquilizer with effects and abuse liability similar to benzodiazepines.²⁶

The feeling produced by high doses of carisoprodol is often described as a potent sedative or euphoric high.

To intensify this feeling, it is frequently abused in combination with opioids (like hydrocodone) and benzodiazepines (like alprazolam).

This dangerous cocktail, sometimes known on the street as the “Holy Trinity” or “Houston Cocktail,” is reported to create a heroin-like effect.²⁷

The real-world consequences of this abuse are stark.

Emergency department visits related to the misuse or abuse of carisoprodol more than doubled between 2004 and 2009, increasing from approximately 16,000 to 32,000 visits annually.²⁷

These statistics underscore the serious public health impact of the non-medical pursuit of the “feelings” these drugs can produce.

4.2 The Rebound Effect: The Feelings of Dependence and Withdrawal

With prolonged or high-dose use, the central nervous system adapts to the constant presence of a muscle relaxant, a phenomenon known as tolerance.

This means that over time, a higher dose is required to achieve the same feeling of relief or sedation.⁷

When the drug is stopped or the dose is reduced too quickly, the now-adapted nervous system can “rebound” into a state of over-activity, leading to a host of distressing and sometimes dangerous withdrawal symptoms.¹⁷

The feeling of withdrawal is often a mirror opposite of the drug’s effects: a state of intense hyper-arousal and discomfort.

Common feelings include severe anxiety, agitation, insomnia, restlessness, tremors, and a painful return of the very muscle spasms the drug was meant to treat.⁵⁹

The specific character of the withdrawal experience can vary depending on the drug.

• Carisoprodol and Diazepam: Abrupt cessation can produce a severe, benzodiazepine-like withdrawal syndrome. The feeling is one of intense anxiety, insomnia, and tremors, which can escalate to life-threatening complications like hallucinations and seizures.⁷
• Baclofen: The feeling of abrupt baclofen withdrawal is particularly dangerous. It can create a state of extreme agitation, confusion, high fever, muscle rigidity, and a significant risk of hallucinations and seizures, often requiring hospitalization.⁵⁴
• Tizanidine: Abruptly stopping tizanidine can feel like a hypertensive crisis. The rebound effect on the adrenergic system can cause a rapid, racing heart (tachycardia) and a sharp, dangerous spike in blood pressure.³²

4.3 A Dangerous Combination: The Synergistic Effect with Alcohol and Other Depressants

Perhaps the most critical safety warning associated with muscle relaxants involves their combination with other CNS depressants, especially alcohol.

When these substances are taken together, their depressant effects are not merely additive; they are synergistic, meaning the combined impact is far greater than the sum of the individual effects.⁷

The subjective experience of this combination is one of overwhelming and dangerous impairment.

The feeling is one of extreme drowsiness, severe dizziness, profound confusion, and a dramatic loss of coordination and judgment.¹⁰

This level of impairment drastically increases the risk of accidents, such as falls or motor vehicle collisions.⁷⁰

The most lethal outcome of this amplified sedation is severe respiratory depression.

Both alcohol and muscle relaxants slow down the brain’s fundamental drive to breathe.

When combined, this effect is magnified to the point where breathing can become dangerously shallow or stop altogether, leading to overdose and death.⁷

The danger is not abstract; data from the Substance Abuse and Mental Health Services Administration (SAMHSA) has shown that up to 18% of emergency department visits involving skeletal muscle relaxants also involved the concurrent use of alcohol, highlighting the frequency and severity of this perilous combination.⁶⁹

Conclusion and Recommendations for Safe Use

The experience of taking a skeletal muscle relaxant is profoundly varied, a multifaceted tapestry woven from the drug’s specific pharmacology, the patient’s unique biology, the condition being treated, and the individual’s intent.

The feeling can range from life-changing relief for a person debilitated by chronic spasticity, to a mild, drowsy inconvenience for someone with an acute back strain, to a dangerous and addictive high for an individual engaged in non-medical misuse.

The sensation is not contained within the pill itself but is created in the complex interaction between the chemical and the person.

The overarching principle derived from this analysis is that the majority of these drugs achieve their effects by depressing the entire central nervous system, a mechanism that is both the source of their therapeutic benefit and the root of their most significant risks.

To navigate this complex landscape safely and effectively, individuals prescribed these medications should adhere to the following evidence-based recommendations:

• Practice Full Disclosure: It is imperative to inform the prescribing healthcare provider of all current medical conditions, paying special attention to any history of kidney disease, liver disease, heart problems, or mental health issues. A complete list of all medications being taken—including prescriptions, over-the-counter drugs, and herbal supplements—is essential to screen for potential interactions.⁵⁷
• Understand Your Medication: Engage in an active dialogue with the physician or pharmacist. Ask why a specific muscle relaxant has been chosen and what specific feelings, both positive and negative, should be anticipated. Understanding the expected experience empowers the patient to better monitor their response.
• Respect the Sedation: The feelings of drowsiness and dizziness are not trivial. Until it is clear how a muscle relaxant affects one’s alertness and coordination, it is crucial to avoid driving, operating heavy machinery, or engaging in any other potentially hazardous activities.⁹
• Abstain from Alcohol and Other Depressants: Due to the risk of synergistic CNS depression, no amount of alcohol is considered safe to consume while taking a centrally-acting muscle relaxant. The same caution applies to other sedating substances, including opioids and benzodiazepines, unless explicitly managed by a single, coordinating physician.¹⁰
• Adhere to Dosing and Duration: Use the medication exactly as prescribed. Do not increase the dose or frequency without consulting a provider. For acute muscle spasms, use should be limited to the shortest effective duration, typically two to three weeks, as evidence for long-term benefit is lacking and risks increase over time.⁵
• Do Not Stop Abruptly: For any muscle relaxant taken for an extended period, especially baclofen, tizanidine, or any benzodiazepine, it is dangerous to stop suddenly. This can provoke a severe withdrawal syndrome. A safe discontinuation requires working with a healthcare provider to create a gradual tapering schedule.³⁶
• Report Alarming Feelings: Certain sensations warrant immediate medical attention. These include feelings of severe confusion, fainting, chest pain, an irregular heartbeat, difficulty breathing, or any signs of a potential allergic reaction such as a rash, hives, or swelling of the face and tongue.⁴⁵ Promptly reporting these symptoms is critical for ensuring safety and well-being.

Works cited

1. Muscle Relaxants – LiverTox – NCBI Bookshelf, accessed on August 10, 2025, https://www.ncbi.nlm.nih.gov/books/NBK548375/
2. Muscle Relaxers: What They Are, Uses, Side Effects & Types – Cleveland Clinic, accessed on August 10, 2025, https://my.clevelandclinic.org/health/treatments/24686-muscle-relaxers
3. Inappropriate Use of Skeletal Muscle Relaxants in Geriatric Patients – U.S. Pharmacist, accessed on August 10, 2025, https://www.uspharmacist.com/article/inappropriate-use-of-skeletal-muscle-relaxants-in-geriatric-patients
4. Muscle relaxant – Wikipedia, accessed on August 10, 2025, https://en.wikipedia.org/wiki/Muscle_relaxant
5. FF #340 Skeletal Muscle Relaxants | Palliative Care Network of Wisconsin, accessed on August 10, 2025, https://www.mypcnow.org/fast-fact/skeletal-muscle-relaxants/
6. Drug Use Criteria: Skeletal Muscle Relaxants – Texas Health and Human Services, accessed on August 10, 2025, https://www.hhs.texas.gov/sites/default/files/documents/july-2024-durb-agenda-item10h.pdf
7. Side Effects of Muscle Relaxers – American Addiction Centers, accessed on August 10, 2025, https://americanaddictioncenters.org/prescription-drugs/side-effects-of-muscle-relaxers
8. FLEXERIL® (CYCLOBENZAPRINE HCl) Tablets – accessdata.fda.gov, accessed on August 10, 2025, https://www.accessdata.fda.gov/drugsatfda_docs/label/2003/017821s045lbl.pdf
9. Cyclobenzaprine (oral route) – Side effects & dosage – Mayo Clinic, accessed on August 10, 2025, https://www.mayoclinic.org/drugs-supplements/cyclobenzaprine-oral-route/description/drg-20063236
10. Alcohol And Muscle Relaxers Shouldn’t Be Mixed. Here’s Why …, accessed on August 10, 2025, https://www.goodrx.com/classes/muscle-relaxants/alcohol-and-muscle-relaxers
11. Muscle relaxants | Pharmacology Education Project, accessed on August 10, 2025, https://www.pharmacologyeducation.org/muscle-relaxants
12. The Problem with Muscle Relaxants – MedShadow Foundation | Independent Health & Wellness Journalism, accessed on August 10, 2025, https://medshadow.org/the-problem-with-muscle-relaxants/
13. Definition of CNS depressant – NCI Dictionary of Cancer Terms, accessed on August 10, 2025, https://www.cancer.gov/publications/dictionaries/cancer-terms/def/cns-depressant
14. Depressants – Alcohol and Drug Foundation, accessed on August 10, 2025, https://adf.org.au/drug-facts/depressants/
15. Depressant – Wikipedia, accessed on August 10, 2025, https://en.wikipedia.org/wiki/Depressant
16. Muscle Relaxants vs. Injections for Herniated Discs: Which Works Better?, accessed on August 10, 2025, https://www.bhpain.com/blog/muscle-relaxants-vs-injections-for-herniated-discs-which-works-better
17. Effects of Depressant Drugs | Drug Free CT, accessed on August 10, 2025, https://www.drugfreect.org/substance-info/pharmaceuticals/depressants/effects-on-the-body/
18. Gamma-Aminobutyric Acid (GABA): What It Is, Function & Benefits – Cleveland Clinic, accessed on August 10, 2025, https://my.clevelandclinic.org/health/articles/22857-gamma-aminobutyric-acid-gaba
19. What is GABA? | Mental Health America, accessed on August 10, 2025, https://mhanational.org/resources/what-is-gaba/
20. Antispasticity drugs: mechanisms of action – PubMed, accessed on August 10, 2025, https://pubmed.ncbi.nlm.nih.gov/2858176/
21. Muscle Relaxants in Pediatric Pain Management – SPPM Newsletter, accessed on August 10, 2025, https://www.pedspainmedicine.org/wp-content/uploads/newsletters/2020/summer/nonopioid/Relaxants.html
22. Muscle Relaxers: List of 17 Prescription Medications – Healthline, accessed on August 10, 2025, https://www.healthline.com/health/muscle-relaxers
23. Are Muscle Relaxers Addictive? Risks & Benefits – Brooks Healing Center, accessed on August 10, 2025, https://brookshealingcenter.com/blog/are-muscle-relaxers-addictive-risks-and-benefits-of-muscle-relaxers/
24. Are Muscle Relaxers Addictive? Safe Use vs. Dependence – Rockland Treatment Center, accessed on August 10, 2025, https://www.rocklandtreatment.com/are-muscle-relaxers-addictive-safe-use-vs-dependence/
25. Oral Muscle Relaxants for the Treatment of Chronic Pain Associated with Cerebral Palsy – PMC – PubMed Central, accessed on August 10, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC7901132/
26. Carisoprodol: abuse potential and withdrawal syndrome – PubMed, accessed on August 10, 2025, https://pubmed.ncbi.nlm.nih.gov/20088817/
27. Carisoprodol Abuse in Adolescence – PMC – PubMed Central, accessed on August 10, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC7746313/
28. Cyclobenzaprine – StatPearls – NCBI Bookshelf, accessed on August 10, 2025, https://www.ncbi.nlm.nih.gov/books/NBK513362/
29. Muscle relaxants for non‐specific low‐back pain – PMC – PubMed Central, accessed on August 10, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC6464310/
30. Muscle relaxers: Types, side effects, safety, and more, accessed on August 10, 2025, https://www.medicalnewstoday.com/articles/muscle-relaxers
31. Zanaflex (Tizanidine): Side Effects, Uses, Dosage, Interactions, Warnings – RxList, accessed on August 10, 2025, https://www.rxlist.com/zanaflex-drug.htm
32. 11 Tizanidine Side Effects You Should Know About – GoodRx, accessed on August 10, 2025, https://www.goodrx.com/tizanidine/typical-tizanidine-side-effects
33. How Does Methocarbamol Work? All About Its Mechanism of Action – GoodRx, accessed on August 10, 2025, https://www.goodrx.com/methocarbamol/methocarbamol-mechanism-of-action
34. Methocarbamol – StatPearls – NCBI Bookshelf, accessed on August 10, 2025, https://www.ncbi.nlm.nih.gov/books/NBK565868/
35. Methocarbamol: Uses, Side Effects, Interactions & More – GoodRx, accessed on August 10, 2025, https://www.goodrx.com/methocarbamol/what-is
36. Muscle Relaxants: Types, Uses, and Side-Effects – Patient.info, accessed on August 10, 2025, https://patient.info/bones-joints-muscles/muscle-relaxants
37. The influence of muscle relaxers on physiologic processes and exercise – Physiopedia, accessed on August 10, 2025, https://www.physio-pedia.com/The_influence_of_muscle_relaxers_on_physiologic_processes_and_exercise
38. Cerebral Palsy and Muscle Relaxants, accessed on August 10, 2025, https://cerebralpalsyguidance.com/cerebral-palsy/treatment/muscle-relaxants/
39. Neuromuscular Blocking Agents – StatPearls – NCBI Bookshelf, accessed on August 10, 2025, https://www.ncbi.nlm.nih.gov/books/NBK537168/
40. Skeletal muscle relaxants – PubMed, accessed on August 10, 2025, https://pubmed.ncbi.nlm.nih.gov/18225966/
41. Baclofen (Lioresal, Fleqsuvy, And Others) Reviews and User …, accessed on August 10, 2025, https://reviews.webmd.com/drugs/drugreview-8615-baclofen-oral
42. Soma Reviews & Ratings (Page 2) – Drugs.com, accessed on August 10, 2025, https://www.drugs.com/comments/carisoprodol/soma.html?page=2
43. Carisoprodol User Reviews & Ratings – Drugs.com, accessed on August 10, 2025, https://www.drugs.com/comments/carisoprodol/
44. Carisoprodol (Soma) Reviews and User Ratings: Effectiveness …, accessed on August 10, 2025, https://reviews.webmd.com/drugs/drugreview-12153-soma-oral
45. Side Effects of Muscle Relaxants: What to Watch for and How to Manage Them, accessed on August 10, 2025, https://orlovichpainmd.com/side-effects-of-muscle-relaxants-what-to-watch-for-and-how-to-manage-them/
46. Side Effects and Risks of Muscle Relaxers – Spine-health, accessed on August 10, 2025, https://www.spine-health.com/treatment/pain-medication/side-effects-and-risks-muscle-relaxers
47. 8 Muscle Relaxer Side Effects: Drowsiness, Dry Mouth, and More – GoodRx, accessed on August 10, 2025, https://www.goodrx.com/classes/muscle-relaxants/side-effects
48. Short & Long-Term Side Effects of Muscle Relaxers – Virtue Recovery Houston TX, accessed on August 10, 2025, https://www.virtuerecoveryhouston.com/side-effects-of-muscle-relaxers/
49. Baclofen vs Carisoprodol Comparison – Drugs.com, accessed on August 10, 2025, https://www.drugs.com/compare/baclofen-vs-carisoprodol
50. Baclofen vs Cyclobenzaprine Comparison – Drugs.com, accessed on August 10, 2025, https://www.drugs.com/compare/baclofen-vs-cyclobenzaprine
51. Tizanidine: MedlinePlus Drug Information, accessed on August 10, 2025, https://medlineplus.gov/druginfo/meds/a601121.html
52. news.westernu.ca, accessed on August 10, 2025, https://news.westernu.ca/2019/11/study-links-popular-muscle-relaxant-to-patient-confusion/#:~:text=Study%20links%20popular%20muscle%20relaxant%20to%20confusion%20%2D%20Western%20News&text=A%20popular%20muscle%20relaxant%20may,after%20being%20prescribed%20the%20drug.
53. Common muscle relaxant linked to severe confusion in patients with kidney disease, accessed on August 10, 2025, https://mediarelations.uwo.ca/2019/11/09/common-muscle-relaxant-linked-to-severe-confusion-in-patients-with-kidney-disease/
54. Baclofen Side Effects: Common, Severe, Long Term – Drugs.com, accessed on August 10, 2025, https://www.drugs.com/sfx/baclofen-side-effects.html
55. Time to consider a skeletal muscle relaxant? – RACGP, accessed on August 10, 2025, https://www1.racgp.org.au/newsgp/clinical/time-to-consider-a-skeletal-muscle-relaxant
56. Methocarbamol (Robaxin) Reviews and User Ratings: Effectiveness, Ease of Use, and Satisfaction – WebMD, accessed on August 10, 2025, https://reviews.webmd.com/drugs/drugreview-8677-methocarbamol-oral
57. Cyclobenzaprine: What Is It? Side Effects & Interactions – Cleveland Clinic, accessed on August 10, 2025, https://my.clevelandclinic.org/health/drugs/19212-cyclobenzaprine-tablets
58. Flexeril Addiction And Abuse, accessed on August 10, 2025, https://www.addictioncenter.com/antidepressants/flexeril/
59. Muscle Relaxers Addiction: Signs, Symptoms, & Treatment – Hope Harbor Wellness, accessed on August 10, 2025, https://hopeharborwellness.com/muscle-relaxers-addiction/
60. Soma Ratings & Reviews by Doctors | Uses & Side Effects – Sermo, accessed on August 10, 2025, https://www.sermo.com/drug-ratings/soma
61. Which Muscle Relaxers Are Best for Neck and Back Pain? – GoodRx, accessed on August 10, 2025, https://www.goodrx.com/classes/muscle-relaxants/best-muscle-relaxants-over-the-counter-prescription-medications
62. Baclofen (oral route) – Side effects & dosage – Mayo Clinic, accessed on August 10, 2025, https://www.mayoclinic.org/drugs-supplements/baclofen-oral-route/description/drg-20067995
63. Tizanidine Addiction: Effects, Risks, Symptoms, Causes & Treatment – The Grove Estate, accessed on August 10, 2025, https://grovetreatment.com/addiction/drug/prescription/tizanidine/
64. Methocarbamol (oral route) – Side effects & dosage – Mayo Clinic, accessed on August 10, 2025, https://www.mayoclinic.org/drugs-supplements/methocarbamol-oral-route/description/drg-20071962
65. Understanding the Addictiveness of Muscle Relaxers – Path To Recovery Detox, accessed on August 10, 2025, https://pathtorecoverydetox.com/understanding-the-addictiveness-of-muscle-relaxers/
66. Are Muscle Relaxers Addictive? | Another Chance Drug and Alcohol Rehab, accessed on August 10, 2025, https://www.anotherchancerehab.com/rehab-blog/are-muscle-relaxers-addictive
67. Are Muscle Relaxers Addictive? Facts You Should Know – Southeast Detox Center, accessed on August 10, 2025, https://southeastdetoxga.com/are-muscle-relaxers-addictive/
68. Muscle Relaxers & Alcohol: Why You Shouldn’t Mix | New Directions, accessed on August 10, 2025, https://www.newdirectionsforwomen.org/the-dangers-of-mixing-alcohol-and-muscle-relaxers/
69. Should you mix muscle relaxants with alcohol? – Drugs.com, accessed on August 10, 2025, https://www.drugs.com/article/muscle-relaxants-alcohol.html
70. The Dangers of Mixing Muscle Relaxers and Alcohol – North Jersey Recovery Center, accessed on August 10, 2025, https://northjerseyrecovery.com/the-dangers-of-mixing-muscle-relaxers-and-alcohol/
71. Mixing Muscle Relaxers and Alcohol: Dangers and Risks | Zinnia Health, accessed on August 10, 2025, https://zinniahealth.com/substance-use/alcohol/with-muscle-relaxers
72. Cyclobenzaprine: MedlinePlus Drug Information, accessed on August 10, 2025, https://medlineplus.gov/druginfo/meds/a682514.html